Action of Amantadine on Post-Stroke Aphasic Patients "CELIC-1"

Completed

Phase 2/3 Results N/A

Eligibility Criteria

Inclusion Criteria

- RANKIN < 3
- > 18 years and < 75
- francophone
- within cognitive deficit known before stroke
- stroke, single in sylvian artery area
- aphasia " non fluent " following a stroke
- stroke > six month
- stable treatment

Exclusion Criteria

- RANKIN > 3
- non francophone
- do not read nor write
- many stroke - against indication
- participated in another clinical trial
- deaf or blind
- intercurrent disease
- new treatment (< 2 months) cognitive
- pregnant or lactating